These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18222118)

  • 1. RanBP10 acts as a novel coactivator for the androgen receptor.
    Harada N; Yokoyama T; Yamaji R; Nakano Y; Inui H
    Biochem Biophys Res Commun; 2008 Mar; 368(1):121-5. PubMed ID: 18222118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARA24/Ran enhances the androgen-dependent NH2- and COOH-terminal interaction of the androgen receptor.
    Harada N; Ohmori Y; Yamaji R; Higashimura Y; Okamoto K; Isohashi F; Nakano Y; Inui H
    Biochem Biophys Res Commun; 2008 Aug; 373(3):373-7. PubMed ID: 18565325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system.
    Wafa LA; Cheng H; Rao MA; Nelson CC; Cox M; Hirst M; Sadowski I; Rennie PS
    Biochem J; 2003 Oct; 375(Pt 2):373-83. PubMed ID: 12864730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
    Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
    Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of RanBPM, a novel coactivator of thyroid hormone receptors.
    Poirier MB; Laflamme L; Langlois MF
    J Mol Endocrinol; 2006 Apr; 36(2):313-25. PubMed ID: 16595702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.
    Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K
    Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor.
    Haelens A; Tanner T; Denayer S; Callewaert L; Claessens F
    Cancer Res; 2007 May; 67(9):4514-23. PubMed ID: 17483368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel MET-interacting protein shares high sequence similarity with RanBPM, but fails to stimulate MET-induced Ras/Erk signaling.
    Wang D; Li Z; Schoen SR; Messing EM; Wu G
    Biochem Biophys Res Commun; 2004 Jan; 313(2):320-6. PubMed ID: 14684163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte nuclear factor-3 alpha (HNF-3alpha) negatively regulates androgen receptor transactivation in prostate cancer cells.
    Lee HJ; Hwang M; Chattopadhyay S; Choi HS; Lee K
    Biochem Biophys Res Commun; 2008 Mar; 367(2):481-6. PubMed ID: 18178153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
    Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO
    Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor.
    Rao MA; Cheng H; Quayle AN; Nishitani H; Nelson CC; Rennie PS
    J Biol Chem; 2002 Dec; 277(50):48020-7. PubMed ID: 12361945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
    Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
    Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ran binding protein RanBPM interacts with TrkA receptor.
    Yuan Y; Fu C; Chen H; Wang X; Deng W; Huang BR
    Neurosci Lett; 2006 Oct; 407(1):26-31. PubMed ID: 16959415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZIP kinase plays a crucial role in androgen receptor-mediated transcription.
    Leister P; Felten A; Chasan AI; Scheidtmann KH
    Oncogene; 2008 May; 27(23):3292-300. PubMed ID: 18084323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor.
    Shen HC; Buchanan G; Butler LM; Prescott J; Henderson M; Tilley WD; Coetzee GA
    Biol Chem; 2005 Jan; 386(1):69-74. PubMed ID: 15843149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An S296R mutation in the human androgen receptor causes activation of the receptor by non-androgenic steroids and stronger inhibition by the nuclear receptor corepressor N-coR.
    Li YD; Lu Y; Chen GC; Lu J
    Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1252-7. PubMed ID: 18637017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
    Peters AA; Buchanan G; Ricciardelli C; Bianco-Miotto T; Centenera MM; Harris JM; Jindal S; Segara D; Jia L; Moore NL; Henshall SM; Birrell SN; Coetzee GA; Sutherland RL; Butler LM; Tilley WD
    Cancer Res; 2009 Aug; 69(15):6131-40. PubMed ID: 19638585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RWDD1 interacts with the ligand binding domain of the androgen receptor and acts as a coactivator of androgen-dependent transactivation.
    Grötsch H; Kunert M; Mooslehner KA; Gao Z; Struve D; Hughes IA; Hiort O; Werner R
    Mol Cell Endocrinol; 2012 Jul; 358(1):53-62. PubMed ID: 22406838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D.
    Shin S; Janknecht R
    Biochem Biophys Res Commun; 2007 Aug; 359(3):742-6. PubMed ID: 17555712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.